Perspective Therapeutics, Inc. (NYSE:CATX) Receives Average Rating of “Buy” from Brokerages
Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has been given a consensus rating of “Buy” by the ten research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating, six have given a buy rating and three have issued a strong buy rating on the […]
Perspective Therapeutics, Inc. (NYSE:CATX – Get Free Report) has been given a consensus rating of “Buy” by the ten research firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold rating, six have given a buy rating and three have issued a strong buy rating on the […]
